Back to search results

Observational Study on Type 2 Diabetes and Kidney Disease in South Carolina Medicaid Patients

This study is looking at information from South Carolina Medicaid patients with Type 2 Diabetes (T2D) and healthy individuals. It's an observational study, meaning researchers will collect health data and blood samples, but you won't receive any new treatments. The goal is to find connections between different health information and the diagnosis or progression of chronic kidney disease (CKD) in people with T2D. By understanding these connections, doctors hope to better predict and potentially prevent or treat T2D and its complications. You may be able to join if you are between 40 and 70 years old, a Medicaid recipient, and can provide blood samples.

Study design
This is an observational study planning to enroll 1200 participants, including those with Type 2 Diabetes and healthy controls.
What's involved
You would need to provide informed consent, authorize release of health information, and give blood samples (up to 70 mL) and other genetic samples.
Compensation
Not stated in the trial record.
Follow-up
Researchers will look at data for up to 24 months after you enroll to identify correlations with chronic kidney disease.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07731399

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

Recruiting
Not specifiedAges 40–70Observational
Guardian Research Network, Inc.
~1,200 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Not applicable- observational study

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identify data elements or combinations of data elements with strong positive or negative correlation to Chronic Kidney Disease diagnosis and/or progression in Type 2 Diabetes patients
Measured over Up to 24 months after enrollment

Conditions

Type 2 Diabetes
Healthy (Controls)

Explore related trials

Type 2 Diabetes Mellitus

Where it's being run

2 sites across 1 states
South Carolina2

Study leadership

  • Randy Axelrod, MD · PRINCIPAL_INVESTIGATOR · Guardian Research Network, Inc.

Who to contact

Katie Poplin
[email protected]
864-656-4503
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

40 to 70 years of age (inclusive) at enrollment
Enrolled as Medicaid recipients
Ability to provide informed consent and authorization for release of relevant protected health information or personal data
Ability to provide a blood sample(s) of up to 70 mL and other required biospecimens, including genetic samples.
Blood level of hemoglobin A1c less than or equal to 5.6% at time of enrollment
No diagnosis of Type 2 diabetes

Exclusion

Pregnancy at time of enrollment (by self-report of pregnancy status)
Lack of fluency in spoken and written English
Type 1 diabetes or any other type of diabetes besides Type 2 diabetes
Active cancer diagnosis or cancer that achieved complete remission within three (3) years prior to enrollment, other than non-melanoma skin cancer (e.g. malignant basal cell neoplasm of skin and/or squamous cell carcinoma of skin)
Major Adverse Cardiovascular Events within two (2) years prior to enrollment
Chronic Obstructive Pulmonary Disease
Cognitive impairment or neurodegenerative diseases (e.g., Alzheimer's disease, dementia, multiple sclerosis, Parkinson's disease, etc.)
Pancreatitis or other diseases of the pancreas (besides diabetes)
The participant is, in the opinion of the investigator, unlikely to be able to complete all study requirements

What this trial measures

  • Identify data elements or combinations of data elements with strong positive or negative correlation to Chronic Kidney Disease diagnosis and/or progression in Type 2 Diabetes patientsUp to 24 months after enrollment

    Perform omics and clinical labs on blood and stool, administer surveys, and analyze medical record data